Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
6,140.00
+60.00 (0.99%)
Dec 12, 2025, 3:19 PM KST
Kwang Dong Pharmaceutical Revenue
Kwang Dong Pharmaceutical had revenue of 444.52B KRW in the quarter ending September 30, 2025, with 4.69% growth. This brings the company's revenue in the last twelve months to 1.64T, up 0.25% year-over-year. In the year 2024, Kwang Dong Pharmaceutical had annual revenue of 1.64T with 8.34% growth.
Revenue (ttm)
1.64T
Revenue Growth
+0.25%
P/S Ratio
0.15
Revenue / Employee
1.60B
Employees
1,021
Market Cap
238.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.64T | 126.26B | 8.34% |
| Dec 31, 2023 | 1.51T | 82.91B | 5.79% |
| Dec 31, 2022 | 1.43T | 93.36B | 6.98% |
| Dec 31, 2021 | 1.34T | 94.41B | 7.59% |
| Dec 31, 2020 | 1.24T | 5.51B | 0.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CJ Cheiljedang | 29.38T |
| E-MART | 28.91T |
| LG H&H | 6.49T |
| KT&G Corporation | 6.42T |
| AMOREPACIFIC Holdings | 4.55T |
| Amorepacific | 4.18T |
| Nongshim | 3.49T |
| ORION | 3.27T |